https://adisinsight.springer.com/trials/700315595?error=cookies_not_supported&code=adc2b391-e1b4-40c7-bc93-4d5d05340c83
Pharmacodynamic Biomarkers to Support Biosimilar Development: Clinical Study 1: Interleukin-5...
This study is designed to assess pharmacokinetics and pharmacodynamics of mepolizumab and reslizumab across an appropriate dose range to inform clinical trial
to supportbiosimilar developmentclinical studybiomarkers
https://www.prweb.com/releases/catalent_agrees_to_biosimilar_development_collaboration_with_zhejiang_hisun_pharma/prweb11732165.htm
Catalent Agrees to Biosimilar Development Collaboration with Zhejiang Hisun Pharma
biosimilar developmentcollaboration withcatalentagreeszhejiang
https://www.biosimilardevelopment.com/
Biosimilar Development
biosimilardevelopment